Analyze Diet

Topic:Oral Administration

Oral administration in horses refers to the delivery of medications, supplements, or nutrients via the mouth. This method is commonly used in equine veterinary medicine for its practicality and ease of use. Oral formulations can include powders, pastes, or liquids, which are designed to be palatable and easily ingested by horses. The effectiveness of oral administration depends on factors such as the horse's digestive physiology, the formulation of the product, and the consistency with which it is administered. This page compiles peer-reviewed research studies and scholarly articles that explore the techniques, efficacy, and considerations of oral administration in equine care.
Route of carbohydrate administration affects early post exercise muscle glycogen storage in horses.
Equine veterinary journal. Supplement    April 4, 2007   Issue 36 590-595 doi: 10.1111/j.2042-3306.2006.tb05610.x
Geor RJ, Larsen L, Waterfall HL, Stewart-Hunt L, McCutcheon LJ.No studies in horses have examined the effect of route of carbohydrate (glucose) administration on the rate of muscle glycogen storage following glycogen-depleting exercise. Objective: Glucose delivery from the gastrointestinal tract limits the rate of muscle glycogen storage following glycogen-depleting exercise. Methods: In a crossover design, 7 fit horses completed treadmill exercise (EX) on 3 occasions to deplete muscle glycogen by approximately 50%. After EX horses received: 1) i.v. glucose infusion (IV; 0.5 g/kg bwt/h for 6 h), 2) oral glucose boluses (OR; 1 g/kg bwt at 0, 2 and 4 h post...
Effects of oral electrolyte supplementation on endurance horses competing in 80 km rides.
Equine veterinary journal. Supplement    April 4, 2007   Issue 36 19-26 doi: 10.1111/j.2042-3306.2006.tb05507.x
Sampieri F, Schott HC, Hinchcliff KW, Geor RJ, Jose-Cunilleras E.There is no evidence that use of oral electrolyte pastes enhances performance in competing endurance horses. Objective: To ascertain whether oral administration of a high dose (HD) of sodium chloride (NaCl) and potassium chloride (KCl) to endurance horses would differentially increase water intake, attenuate bodyweight (bwt) loss and improve performance when compared to a low dose (LD). Methods: A randomised, blinded, crossover study was conducted on 8 horses participating in two 80 km rides (same course, 28 days apart). Thirty minutes before and at 40 km of the first ride 4, horses received o...
Oral and intravenous administration of nimesulide in the horse: rational dosage regimen from pharmacokinetic and pharmacodynamic data.
Equine veterinary journal    March 24, 2007   Volume 39, Issue 2 136-142 doi: 10.2746/042516407x159123
Villa R, Cagnardi P, Belloli C, Zonca A, Zizzadoro C, Ferro E, Carli S.The selective COX-2-inhibitor nimesulide is used extra-label in equine veterinary practice as an anti-inflammatory agent. However, there are no data on which to base the rational use of the drug in this species. Objective: To determine the effective COX selectivity of nimesulide in the horse, and suggest a suitable dosing schedule. Methods: The pharmacokinetics of nimesulide in the horse after oral administration (1 mg/kg bwt), and oral and i.v. administration (1.5 mg/kg bwt) were investigated, effects of feeding status on bioavailability determined, and plasma protein binding of the drug and ...
A field study on the efficacy of doramectin against strongyles and its egg reappearance period in horses.
DTW. Deutsche tierarztliche Wochenschrift    March 8, 2007   Volume 114, Issue 2 64-66 
Cirak VY, Güleğen E, Yildirim F, Durmaz M.The aim of the present study was to determine the efficacy and the so-called "egg reappearance period" (ERP) of doramectin in horses naturally infected with strongyles during a period of 34 weeks. A group of yearlings of 10 animals was treated intramuscularly with doramectin at a dose rate of 0.2 mg/kg bodyweight (BW) at the begin of the grazing season. To obtain comparable data, another group of yearlings (n = 10) was treated orally with ivermectin at a dose rate of 0.2 mg/kg BW. Individual faecal samples were examined for strongyle egg counts per gram of faeces (EPG) in two-week intervals. T...
Equine gastric ulcer syndrome in adult horses: a review.
New Zealand veterinary journal    March 7, 2007   Volume 55, Issue 1 1-12 doi: 10.1080/00480169.2007.36728
Bell RJ, Mogg TD, Kingston JK.In recent years, gastric ulceration has been recognised as a common, possibly performance-limiting disease of adult horses. Here, we aim to provide the reader with a useful review of recent literature covering all aspects of equine gastric ulcer syndrome (EGUS) in adult horses. The anatomy and physiology of the stomach, with particular reference to secretion of acid and mucosal protective mechanisms, are reviewed, as are the differing theories relating to the aetiopathogenesis of gastric ulceration. We also explore the possible influence of various management factors on development of the dise...
Effects of continuous oral administration of phenylbutazone on biomarkers of cartilage and bone metabolism in horses.
American journal of veterinary research    February 3, 2007   Volume 68, Issue 2 128-133 doi: 10.2460/ajvr.68.2.128
Fradette ME, Céleste C, Richard H, Beauchamp G, Laverty S.To evaluate the effects of continuous oral administration of phenylbutazone on serum and synovial fluid biomarkers of skeletal matrix metabolism in horses. Methods: 11 adult female horses without clinical or radiographic evidence of joint disease. Methods: Horses were randomly assigned to control or treatment groups. Phenylbutazone was administered orally twice daily at a dose of 4.4 mg/kg for 3 days to the treatment group and subsequently at a dose of 2.2 mg/kg for 7 days. Serum and radiocarpal synovial fluid samples were obtained at baseline and thereafter at regular intervals for 4 weeks. B...
Pharmacokinetics of etodolac in the horse following oral and intravenous administration.
Journal of veterinary pharmacology and therapeutics    January 16, 2007   Volume 30, Issue 1 43-48 doi: 10.1111/j.1365-2885.2007.00811.x
Davis JL, Papich MG, Morton AJ, Gayle J, Blikslager AT, Campbell NB.The purpose of this study was to determine the pharmacokinetics of etodolac following oral and intravenous administration to six horses. Additionally, in vitro cyclooxygenase (COX) selectivity assays were performed using equine whole blood. Using a randomized two-way crossover design, horses were administered etodolac (20 mg/kg) orally or intravenously, with a minimum 3-week washout period. Plasma samples were collected after administration for analysis using high pressure liquid chromatography with ultraviolet detection. Following intravenous administration, etodolac had a mean plasma half-li...
Enteral fluid therapy in large animals.
Australian veterinary journal    December 13, 2006   Volume 84, Issue 12 447-451 doi: 10.1111/j.1751-0813.2006.00072.x
Rainger JE, Dart AJ.Enteral fluids administered alone, or in conjunction with intravenous fluids, are reported to be useful for the treatment of dehydration and electrolyte loss associated with diarrhoea in a number of species, following exercise in horses and for feed impaction of the large intestine of horses. Enteral fluids are suitable for treatment of mild to moderately dehydrated patients with some intact intestinal epithelium and motile small intestine. In patients that will drink voluntarily or tolerate nasal intubation the use of enteral fluids may avoid the complications associated with intravenous flui...
Efficacy of oseltamivir phosphate to horses inoculated with equine influenza A virus.
The Journal of veterinary medical science    October 5, 2006   Volume 68, Issue 9 923-928 doi: 10.1292/jvms.68.923
Yamanaka T, Tsujimura K, Kondo T, Hobo S, Matsumura T.We investigated the efficacy of the oral administration of oseltamivir phosphate (OP) in horses experimentally infected with equine influenza A virus (H3N8). Nine horses were divided into three horses each of control, treatment and prophylaxis groups. An administration protocol for the treatment group (2 mg/kg of body weight, twice a day for five days) was started immediately after the onset of pyrexia (above 38.9 degrees C). An administration protocol for the prophylaxis group (2 mg/kg of body weight, once a day for five days) was started on a day before viral inoculation. In the treatment gr...
Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals.
American journal of veterinary research    October 4, 2006   Volume 67, Issue 10 1681-1686 doi: 10.2460/ajvr.67.10.1681
Womble AY, Giguère S, Lee EA, Vickroy TW.To determine pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar (BAL) cells of foals. Methods: 6 healthy 2-to 3-week-old foals. Methods: In a crossover design, clarithromycin (7.5 mg/kg) was administered to each foal via IV and intragastric (IG) routes. After the initial IG administration, 5 additional doses were administered IG at 12-hour intervals. Concentrations of clarithromycin and its 14-hydroxy metabolite were measured in serum by use of high-performance liquid chromatography. A microbiologic assay was used to measure clarithromycin activity in seru...
Pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite after oral and intravenous administration of pentoxifylline to healthy adult horses.
American journal of veterinary research    September 5, 2006   Volume 67, Issue 9 1621-1627 doi: 10.2460/ajvr.67.9.1621
Liska DA, Akucewich LH, Marsella R, Maxwell LK, Barbara JE, Cole CA.To determine serum pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite in horses after administration of a single IV dose and after single and multiple oral doses. Methods: 8 healthy adult horses. Methods: A crossover study design was used with a washout period of 6 days between treatments. Treatments were IV administration of a single dose of pentoxifylline (8.5 mg/kg) and oral administration of generic sustained-release pentoxifylline (10 mg/kg, q 12 h, for 8 days). Blood samples were collected 0, 1, 3, 6, 12, 20, 30, and 45 minutes and 1, 2, 4, 6, 8, and 12 hours after IV a...
A stereochemical examination of the equine metabolism of 17alpha-methyltestosterone.
Analytica chimica acta    August 18, 2006   Volume 581, Issue 2 377-387 doi: 10.1016/j.aca.2006.08.025
McKinney AR, Suann CJ, Stenhouse AM.An investigation was conducted into the stereochemistry of the equine urinary metabolites of 17alpha-methyltestosterone observed after oral administration. Standards of the complete range of C3/C5/C16 stereoisomeric 17alpha-methylandrostane-3,17beta-diols, 17alpha-methylandrostane-3,16,17beta-triols and 17alpha-hydroxymethylandrostane-3,17beta-diols were purchased or synthesised, and were used to unequivocally identify the absolute structures of the metabolites. Phase I metabolism was found to involve combinations of Delta(4)-3-ketone reduction with both 5alpha,3beta- and 5beta,3alpha-stereoch...
Oral hyaluronan gel reduces post operative tarsocrural effusion in the yearling Thoroughbred.
Equine veterinary journal    July 27, 2006   Volume 38, Issue 4 375-378 doi: 10.2746/042516406777749218
Bergin BJ, Pierce SW, Bramlage LR, Stromberg A.Hyaluronan (HA) has been used to treat joint disease via intra-articular, i.v. and oral administration. The efficacy of intra-articular and i.v. use has been evaluated but the oral route has yet to be examined. Objective: To determine the effect of oral hyaluronan gel on joint effusion following arthroscopic surgery for osteochondritis dissecans (OCD) of the tarsocrural joint of yearling Thoroughbreds. Methods: Forty-eight yearlings diagnosed with unilateral or bilateral osteochondritis dessicans (OCD) of the tarsus were arbitrarily chosen prior to arthroscopic surgery. The yearlings were incl...
Oral and intravenous carbohydrate challenges decrease active ghrelin concentrations and alter hormones related to control of energy metabolism in horses.
Journal of animal science    June 16, 2006   Volume 84, Issue 7 1682-1690 doi: 10.2527/jas.2005-484
Gordon ME, McKeever KH.This study tested the hypothesis that grain and intravenous dextrose challenges would alter plasma concentrations of active ghrelin, adiponectin, leptin, glucose, insulin, and cortisol in Standardbred mares. To deliver 0.5 g of glucose (dextrose solution for the intravenous test)/kg of BW, mares received intravenous dextrose (50% solution) or oral grain administration in 2 trials. In response to the oral grain challenge, plasma glucose and insulin concentrations increased (P < 0.001) by 56 and 802%, respectively. Plasma ghrelin concentration initially decreased (P < 0.001) by 40%, then s...
Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys.
Veterinary journal (London, England : 1997)    June 15, 2006   Volume 172, Issue 1 166-172 doi: 10.1016/j.tvjl.2005.02.022
Gokbulut C, Akar F, McKellar QA.Fenbendazole (FBZ), oxfendazole (fenbendazole sulphoxide, FBZSO), and albendazole (ABZ) were administered orally to donkeys at 10mg/kg bodyweight. Blood and faecal samples were collected from 1 to 120 h post-treatment. The plasma and faecal samples were analysed by high performance liquid chromatography (HPLC). The parent molecule and its sulphoxide and sulphone (FBZSO(2)) metabolites did not reach detectable concentrations in any plasma samples following FBZ administration. ABZ was also not detected in any plasma samples, but its sulphoxide and sulphone metabolites were detected, demonstratin...
Efficacy of moxidectin 2 per cent oral gel against cyathostomins, particularly third-stage inhibited larvae, in horses.
The Veterinary record    June 6, 2006   Volume 158, Issue 22 766-767 doi: 10.1136/vr.158.22.766
Bairden K, Davies HS, Gibson NR, Hood AJ, Parker LD.No abstract available
Pharmacokinetics of voriconazole after oral and intravenous administration to horses.
American journal of veterinary research    June 3, 2006   Volume 67, Issue 6 1070-1075 doi: 10.2460/ajvr.67.6.1070
Davis JL, Salmon JH, Papich MG.To characterize pharmacokinetics of voriconazole in horses after oral and IV administration and determine the in vitro physicochemical characteristics of the drug that may affect oral absorption and tissue distribution. Methods: 6 adult horses. Methods: Horses were administered voriconazole (1 mg/kg, IV, or 4 mg/kg, PO), and plasma concentrations were measured by use of high-performance liquid chromatography. In vitro plasma protein binding and the octanol:water partition coefficient were also assessed. Results: Voriconazole was adequately absorbed after oral administration in horses, with a s...
Pharmacokinetics of acyclovir after single intravenous and oral administration to adult horses.
Journal of veterinary internal medicine    June 1, 2006   Volume 20, Issue 3 589-594 doi: 10.1892/0891-6640(2006)20[589:poaasi]2.0.co;2
Bentz BG, Maxwell LK, Erkert RS, Royer CM, Davis MS, MacAllister CG, Clarke CR.The purpose of the study reported here was to describe the bioavailability and pharmacokinetics of acyclovir after intravenous and oral administration to horses. Six healthy adult horses were used in a randomized cross-over study with a 3 x 3 Latin square design. Three treatments were administered to each horse: 10 mg of injectable acyclovir/kg of body weight in 1 L of normal saline delivered as an infusion over 15 minutes; 10 mg of acyclovir/kg in tablets by nasogastric intubation; and 20 mg of acyclovir/kg in tablets by nasogastric intubation. A 2-week washout period was provided between eac...
The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration.
Journal of veterinary pharmacology and therapeutics    May 4, 2006   Volume 29, Issue 3 191-197 doi: 10.1111/j.1365-2885.2006.00737.x
Davis JL, Papich MG, Weingarten A.The purpose of this study was to determine the pharmacokinetics and physicochemical characteristics of orbifloxacin in the horse. Six healthy adult horses were administered oral and intravenous orbifloxacin at a dose of 2.5 mg/kg. Plasma samples were collected and analyzed by high-pressure liquid chromatography with ultraviolet detection. Plasma protein binding and lipophilicity were determined in vitro. Following i.v. administration, orbifloxacin had a terminal half-life (t1/2) of 5.08 h and a volume of distribution (V(d(SS))) of 1.58 L/kg. Following oral administration, the average maximum p...
New therapeutic approaches for equine protozoal myeloencephalitis: pharmacokinetics of diclazuril sodium salts in horses.
Veterinary therapeutics : research in applied veterinary medicine    April 7, 2006   Volume 7, Issue 1 52-72 
Dirikolu L, Karpiesiuk W, Lehner AF, Hughes C, Woods WE, Harkins JD, Boyles J, Atkinson A, Granstrom DE, Tobin T.Diclazuril is a triazine-based antiprotozoal agent which may have clinical application in the treatment of equine protozoal myeloencephalomyelitis (EPM). In this study, the use of the sodium salt diclazuril to increase the apparent bioavailability of diclazuril for the treatment and prophylaxis of EPM and various other Apicomplexan mediated diseases is described. In this study, diclazuril sodium salt was synthesized and administered to horses as diclazuril sodium salt formulations. The absorption, distribution, and clearance of diclazuril sodium salt in the horse are described. Diclazuril was ...
Use of force plate analysis to assess the analgesic effects of etodolac in horses with navicular syndrome.
American journal of veterinary research    April 4, 2006   Volume 67, Issue 4 557-561 doi: 10.2460/ajvr.67.4.557
Symonds KD, MacAllister CG, Erkert RS, Payton ME.To evaluate the musculoskeletal analgesic effect of etodolac administered PO every 12 or 24 hours in chronically lame horses by use of force plate analysis. Methods: 22 horses with navicular syndrome. Methods: Horses received etodolac (23 mg/kg, PO, q 12 h; n = 7), etodolac (23 mg/kg, PO, q 24 h; 8), or corn syrup (20 mL, PO, q 24 h; control treatment; 7) for 3 days. Combined forelimb peak vertical ground reaction force (PVF) was measured via force plate analysis before the first treatment (baseline) and at 6, 12, 24, and 36 hours after the last treatment. Differences in mean PVF (mPVF) betwee...
Target animal safety and tolerance study of pyrantel pamoate paste (19.13% w/w pyrantel base) administered orally to horses.
Veterinary therapeutics : research in applied veterinary medicine    March 22, 2006   Volume 6, Issue 4 311-324 
Marchiondo AA, TerHune TN, Herrick RL.Pyrantel pamoate paste (19.13% w/w pyrantel base) for the treatment of tapeworm, Anoplocephala spp was evaluated for target animal safety and tolerance in horses treated orally at 0, 1, 3, 5, and 10 times the clinical dose of 13.2 mg pyrantel base/kg body weight administered daily for six consecutive days. Parameters evaluated included clinical signs, food and water consumption, body weights, physical examinations, clinical pathology (hematology, coagulation, serum chemistry, urinalyses, and fecal examinations), complete necropsy, organ weights, and histopathology. No adverse events or test ar...
Dose-confirmation studies of the cestocidal activity of pyrantel pamoate paste in horses.
Veterinary parasitology    March 13, 2006   Volume 138, Issue 3-4 234-239 doi: 10.1016/j.vetpar.2006.02.008
Reinemeyer CR, Hutchens DE, Eckblad WP, Marchiondo AA, Shugart JI.Dose confirmation studies of the cestocidal activity of pyrantel pamoate paste were conducted at two sites in North America during 2001. Horses with naturally-acquired cestode infections were identified by detection of typical Anoplocephala spp. eggs in feces collected between 7 and 92 days prior to treatment. Twenty and 22 horses were enrolled at Site 1 (Urbana, IL) and Site 2 (Knoxville, TN), respectively. Candidate horses were acclimated to study conditions for 14 days, ranked by length of interval since coprologic confirmation, and allocated randomly to one of two treatment groups: (T1) py...
Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment.
Journal of veterinary pharmacology and therapeutics    March 7, 2006   Volume 29, Issue 2 129-135 doi: 10.1111/j.1365-2885.2006.00724.x
Olsén L, Ingvast-Larsson C, Larsson P, Broström H, Bondesson U, Sundqvist M, Tjälve H.The pharmacokinetics and the effects on inhibition of histamine-induced cutaneous wheal formation of the histamine H1-antagonist fexofenadine were studied in horse. The effect of ivermectin pretreatment on the pharmacokinetics of fexofenadine was also examined. After intravenous infusion of fexofenadine at 0.7 mg/kg bw the mean terminal half-life was 2.4 h (range: 2.0-2.7 h), the apparent volume of distribution 0.8 L/kg (0.5-0.9 L/kg), and the total body clearance 0.8 L/h/kg (0.6-1.2 L/h/kg). After oral administration of fexofenadine at 10 mg/kg bw bioavailability was 2.6% (1.9-2.9%). Ivermect...
Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.
American journal of veterinary research    March 2, 2006   Volume 67, Issue 3 448-454 doi: 10.2460/ajvr.67.3.448
De Clercq D, Baert K, Croubels S, van Loon G, Maes A, Tavernier R, Deprez P, De Backer P.To determine the clinical effects and pharmacokinetics of amiodarone after single doses of 5 mg/kg administered orally or intravenously. Methods: 6 healthy adult horses. Methods: In a cross over study, clinical signs and electrocardiographic variables were monitored and plasma and urine samples were collected. A liquid chromatography-mass spectrometry method was used to determine the percentage of protein binding and to measure plasma and urine concentrations of amiodarone and the active metabolite desethylamiodarone. Results: No adverse clinical signs were observed. After IV administration, m...
Successful conversion of equine atrial fibrillation using oral flecainide.
Journal of veterinary internal medicine    February 25, 2006   Volume 20, Issue 1 207-209 doi: 10.1892/0891-6640(2006)20[207:scoeaf]2.0.co;2
Risberg AI, McGuirk SM.No abstract available
Pharmacokinetics and tissue distribution of doxycycline after oral administration of single and multiple doses in horses.
American journal of veterinary research    February 4, 2006   Volume 67, Issue 2 310-316 doi: 10.2460/ajvr.67.2.310
Davis JL, Salmon JH, Papich MG.To determine pharmacokinetics, safety, and penetration into interstitial fluid (ISF), polymorphonuclear leukocytes (PMNLs), and aqueous humor of doxycycline after oral administration of single and multiple doses in horses. Methods: 6 adult horses. Methods: The effect of feeding on drug absorption was determined. Plasma samples were obtained after administration of single or multiple doses of doxycycline (20 mg/kg) via nasogastric tube. Additionally, ISF, PMNLs, and aqueous humor samples were obtained after the final administration. Horses were monitored for adverse reactions. Results: Feeding ...
Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses.
American journal of veterinary research    February 4, 2006   Volume 67, Issue 2 296-301 doi: 10.2460/ajvr.67.2.296
Clode AB, Davis JL, Salmon J, Michau TM, Gilger BC.To determine penetration of topically and orally administered voriconazole into ocular tissues and evaluate concentrations of the drug in blood and signs of toxicosis after topical application in horses. Methods: 11 healthy adult horses. Methods: Each eye in 6 horses was treated with a single concentration (0.5%, 1.0%, or 3.0%) of a topically administered voriconazole solution every 4 hours for 7 doses. Anterior chamber paracentesis was performed and plasma samples were collected after application of the final dose. Voriconazole concentrations in aqueous humor (AH) and plasma were measured via...
Evaluation of glucosamine levels in commercial equine oral supplements for joints.
Equine veterinary journal    January 18, 2006   Volume 38, Issue 1 93-95 doi: 10.2746/042516406775374306
Oke S, Aghazadeh-Habashi A, Weese JS, Jamali F.No abstract available
Effects of treatment with omeprazole or ranitidine on gastric squamous ulceration in racing Thoroughbreds.
Journal of the American Veterinary Medical Association    November 30, 2005   Volume 227, Issue 10 1636-1639 doi: 10.2460/javma.2005.227.1636
Lester GD, Smith RL, Robertson ID.To compare the effects of oral administration of omeprazole and ranitidine on gastric squamous ulceration in Thoroughbreds in race training. Methods: Modified crossover study. Methods: 60 Thoroughbreds in race training with gastric squamous mucosal ulceration. Methods: Horses were randomly allocated into 3 groups. Group 1 received no treatment for 28 days followed by administration of omeprazole (4 mg/kg [1.8 mg/lb], PO, once daily) for 28 days; group 2 received omeprazole (4 mg/kg, PO, once daily) for 28 days followed by no treatment for 28 days; and group 3 received ranitidine (6.6 mg/kg [3....
1 12 13 14 15 16 26